Remove Allergies Remove Medicine Remove Protein Remove Research
article thumbnail

Asthma Drug Xolair Wins FDA Approval as First Treatment for Multiple Food Allergies

XTalks

The class of IgE-mediated food allergies includes 160 foods, with peanuts, milk, eggs, wheat, soy and tree nuts being the most common ones. According to the Centers for Disease Control and Prevention (CDC), almost six percent of people in the US in 2021 had a food allergy. However, the treatment is restricted to peanut allergy.

Allergies 100
article thumbnail

No drugs for prions: could new approaches alleviate therapeutic scarcity?

Pharmaceutical Technology

As per the prevailing prion theory, a misfolded version of a normal cell-surface protein acts as the chief infectious agent. It is ultra-rare,” says Jesús Rodriguez Requena, PhD, associate professor in the Department of Medicine at the University of Santiago de Compostela. And then comes the question of the right target.

Drugs 299
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Protein produced by the nervous system may help treatments for inflammatory diseases

Scienmag

Rutgers researchers discovered a new role the protein may have in helping to treat allergies, asthma, COPD A Rutgers-led team may have found the key to treating inflammatory diseases like asthma, allergies, chronic fibrosis and chronic obstructive pulmonary disease (COPD).

Protein 40
article thumbnail

Inflammation-fighting protein could improve treatment of rheumatoid arthritis

Scienmag

– New research led by scientists at Washington State University has found that a protein known as GBP5 appears to play a key role in suppressing inflammation in rheumatoid arthritis, a potentially debilitating disease in which the immune system mistakenly attacks the […].

Protein 88
article thumbnail

A T-cell stimulatory protein and interleukin-10 synergize to prevent gut inflammation

Scienmag

This study will aid the understanding of, and future research on, inflammatory bowel disease, which afflicts about 1.6 – Researchers have found an unexpected synergy between a T-cell stimulatory protein — the ICOS ligand — and interleukin-10, an immunoregulatory cytokine, to prevent inflammatory bowel disease in mice.

Protein 91
article thumbnail

Rensselaer team receives NIAID grant to develop antiviral drug for Covid-19

Pharmaceutical Technology

Researchers at the Rensselaer Polytechnic Institute in the US have received a five-year, $3.5m grant from the National Institutes of Health (NIH) unit National Institute of Allergy and Infectious Diseases (NIAID) for developing a Covid-19 oral antiviral drug. Those drugs that hinder only CLpro did not enhance the effects of remdesivir.

article thumbnail

World AIDS Vaccine Day 2024: Prospects in HIV Vaccine Research

XTalks

This day isn’t just a reminder of the medical challenge to find a safe and effective HIV vaccine, but also a tribute to the undertaking that has both challenged and intrigued researchers for over three decades. The Current Landscape of HIV Vaccine Research Today, the landscape of HIV research is filled with innovation.